评估1型人类免疫缺陷病毒嗜性：使用具有复制能力的病毒与血浆来源的假型病毒体的检测方法比较。
Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virions.
作者信息
Hosoya Noriaki, Su Zhaohui, Wilkin Timothy, Gulick Roy M, Flexner Charles, Hughes Michael D, Skolnik Paul R, Giguel Françoise, Greaves Wayne L, Coakley Eoin, Kuritzkes Daniel R
机构信息
Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
出版信息
J Clin Microbiol. 2009 Aug;47(8):2604-6. doi: 10.1128/JCM.00632-09. Epub 2009 Jun 3.
Abstract
Detection of CXCR4-using human immunodeficiency virus by the Trofile assay was compared to that by assays using virus isolates or replication-competent recombinants. Concordance with the Trofile assay was good, but assays using replicating viruses did not increase substantially the ability to detect the presence of CXCR4-using virus.
摘要
通过Trofile检测法检测使用CXCR4的人类免疫缺陷病毒，并与使用病毒分离株或具有复制能力的重组体的检测法进行比较。与Trofile检测法的一致性良好，但使用复制病毒的检测法并未显著提高检测使用CXCR4病毒存在的能力。
相似文献
1
Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virions.
J Clin Microbiol. 2009 Aug;47(8):2604-6. doi: 10.1128/JCM.00632-09. Epub 2009 Jun 3.
2
Comparison of human immunodeficiency virus type 1 tropism profiles in clinical samples by the Trofile and MT-2 assays.
Antimicrob Agents Chemother. 2009 Nov;53(11):4686-93. doi: 10.1128/AAC.00229-09. Epub 2009 Aug 17.
3
Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism.
Antimicrob Agents Chemother. 2007 Feb;51(2):566-75. doi: 10.1128/AAC.00853-06. Epub 2006 Nov 20.
4
Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage.
J Clin Virol. 2010 Feb;47(2):126-30. doi: 10.1016/j.jcv.2009.11.018. Epub 2009 Dec 16.
5
Correlation between genotypic (V3 population sequencing) and phenotypic (Trofile ES) methods of characterizing co-receptor usage of HIV-1 from 200 treatment-naïve HIV patients screened for Study A4001078.
Antiviral Res. 2013 Jan;97(1):60-5. doi: 10.1016/j.antiviral.2012.11.002. Epub 2012 Nov 16.
6
Phenotypic assays for the determination of coreceptor tropism in HIV-1 infected individuals.
Eur J Med Res. 2007 Oct 15;12(9):463-72.
7
Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping.
Retrovirology. 2010 Jun 30;7:56. doi: 10.1186/1742-4690-7-56.
8
Human immunodeficiency virus type 1 IIIB selected for replication in vivo exhibits increased envelope glycoproteins in virions without alteration in coreceptor usage: separation of in vivo replication from macrophage tropism.
J Virol. 2001 Sep;75(18):8498-506. doi: 10.1128/jvi.75.18.8498-8506.2001.
9
Improved detection of CXCR4-using HIV by V3 genotyping: application of population-based and "deep" sequencing to plasma RNA and proviral DNA.
J Acquir Immune Defic Syndr. 2010 Aug;54(5):506-10. doi: 10.1097/QAI.0b013e3181d0558f.
10
Current tests to evaluate HIV-1 coreceptor tropism.
Curr Opin HIV AIDS. 2009 Mar;4(2):136-42. doi: 10.1097/COH.0b013e328322f973.
引用本文的文献
1
HIV-1 tropism testing in subjects achieving undetectable HIV-1 RNA: diagnostic accuracy, viral evolution and compartmentalization.
PLoS One. 2013 Aug 1;8(8):e67085. doi: 10.1371/journal.pone.0067085. Print 2013.
2
TROCAI (tropism coreceptor assay information): a new phenotypic tropism test and its correlation with Trofile enhanced sensitivity and genotypic approaches.
J Clin Microbiol. 2010 Dec;48(12):4453-8. doi: 10.1128/JCM.00953-10. Epub 2010 Oct 13.
3
The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolates.
J Virol Methods. 2010 Oct;169(1):39-46. doi: 10.1016/j.jviromet.2010.06.012. Epub 2010 Jun 25.
本文引用的文献
1
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.
N Engl J Med. 2008 Oct 2;359(14):1442-55. doi: 10.1056/NEJMoa0803154.
2
Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.
J Infect Dis. 2007 Jul 15;196(2):304-12. doi: 10.1086/518797. Epub 2007 Jun 5.
3
HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
Clin Infect Dis. 2007 Feb 15;44(4):591-5. doi: 10.1086/511035. Epub 2007 Jan 17.
4
Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism.
Antimicrob Agents Chemother. 2007 Feb;51(2):566-75. doi: 10.1128/AAC.00853-06. Epub 2006 Nov 20.
5
Relative replicative fitness of human immunodeficiency virus type 1 mutants resistant to enfuvirtide (T-20).
J Virol. 2004 May;78(9):4628-37. doi: 10.1128/jvi.78.9.4628-4637.2004.
6
Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliter.
J Clin Microbiol. 2002 Jun;40(6):2089-94. doi: 10.1128/JCM.40.6.2089-2094.2002.
7
Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1.
J Virol. 1998 Nov;72(11):9307-12. doi: 10.1128/JVI.72.11.9307-9312.1998.
8
Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.
J Virol. 1997 Oct;71(10):7478-87. doi: 10.1128/JVI.71.10.7478-7487.1997.
9
Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry.
J Virol. 1996 Dec;70(12):8355-60. doi: 10.1128/JVI.70.12.8355-8360.1996.
10
Standardized microtiter assay for determination of syncytium-inducing phenotypes of clinical human immunodeficiency virus type 1 isolates.
J Clin Microbiol. 1994 Sep;32(9):2291-4. doi: 10.1128/jcm.32.9.2291-2294.1994.
Zotero 插件